CONTINUING EDUCATION (CE) LANGUAGE

Title:                   Clinical Utility of Integrating Functional Luminal Imaging probe with Standard EGD for Comprehensive Esophageal Assessment

Date:                   May 6, 2026

Location:             Online

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). NASPGHAN is accredited by the ACCME to provide continuing medical education for physicians.

ACCME provider number: 0005000

Credit Designation Statement

NASPGHAN designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

ABP MOC Part 2 Credits

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn up to 1.5 MOC Part 2 points for the live webinar in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Participant must complete the assessment within 30 days of the activity.

Clinical Utility of Integrating Functional Luminal Imaging probe, (using impedance planimetry technology) with Standard EGD for Comprehensive Esophageal Assessment will explore the role of functional luminal imaging probe technology in pediatric gastroenterology and its growing value in the evaluation of esophageal function during endoscopy.

Using high-resolution impedance planimetry, this technology allows for real-time assessment of the esophagus, pylorus, and anal sphincters, offering important insights into esophagogastric junction function and esophageal contractile activity. The session will review the technology’s design and system features, practical considerations for incorporating testing into routine endoscopic procedures, and key principles of data interpretation, including diameter, cross-sectional area, compliance, distensibility, and contractile response patterns.

Through case-based discussion and a focus on pediatric-specific applications, participants will gain practical knowledge to support more accurate diagnosis, clinical decision-making, and long-term management of complex esophageal disorders in children.  Join our experts on May 6!

In this episode, Dr. Jordan Whatley and Dr. Amber Hildreth talk to Dr. Pete Duncan, Pediatric Gastroenterologist at Boston Children's Hospital who specializes in Aerodigestive Medicine and leads the NASPGHAN Aerodigestive Special Interest Group. We talk about the evaluation and management of oropharyngeal dysphagia and aspiration in children and how the approach to these issues has changed over time. 

For Canadian listeners:

Please note that all listed Bowel Sounds episodes are peer-reviewed and that listening to episodes is considered a Section Two Scanning Activity by the Royal College of Physicians and Surgeons of Canada Maintenance of Certification program. Each episode is valued at 0.5 Section Two Credits. Content is valid on the date recorded but recommendations may change over time. You can document your listening and obtain your CME credits at https://mainport.royalcollege....

CONTINUING EDUCATION (CE) LANGUAGE

Title:                   MASLD: What’s That Again?

Date:                   March 18, 2026

Location:             Online

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). NASPGHAN is accredited by the ACCME to provide continuing medical education for physicians.

ACCME provider number: 0005000

Credit Designation Statement

NASPGHAN designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

ABP MOC Part 2 Credits

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn up to 1.5 MOC Part 2 points for the live webinar in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Participant must complete the assessment within 30 days of the activity.

Obesity is a pervasive form of malnutrition that drives the development of MASLD, now the leading cause of chronic liver disease worldwide. Emerging evidence suggests that even moderate weight loss can yield significant improvements in liver steatosis, inflammation, and fibrosis. Proper nutrition may not only support weight loss, but also directly counteract steatosis and its progression.  MASLD: What’s That Again? is an updated review of the AASLD guidance document on Pediatric MASLD. In addition, it brings a summary of the key findings from the JPGN publication, “Nutritional Treatment of Obesity & Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Children. 

CONTINUING EDUCATION (CE) LANGUAGE

Title:                   MASLD: What’s That Again?

Date:                   March 18, 2026

Location:             Online

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). NASPGHAN is accredited by the ACCME to provide continuing medical education for physicians.

ACCME provider number: 0005000

Credit Designation Statement

NASPGHAN designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

ABP MOC Part 2 Credits

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn up to 1.5 MOC Part 2 points for the live webinar in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Participant must complete the assessment within 30 days of the activity.

Obesity is a pervasive form of malnutrition that drives the development of MASLD, now the leading cause of chronic liver disease worldwide. Emerging evidence suggests that even moderate weight loss can yield significant improvements in liver steatosis, inflammation, and fibrosis. Proper nutrition may not only support weight loss, but also directly counteract steatosis and its progression.  MASLD: What’s That Again? is an updated review of the AASLD guidance document on Pediatric MASLD. In addition, it brings a summary of the key findings from the JPGN publication, “Nutritional Treatment of Obesity & Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Children. 

In this episode of Bowel Sounds, hosts Drs. Amber Hildreth and Jason Silverman talk to Dr. Saul Karpen, the inaugural chief scientific officer for the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at Virginia Commonwealth University, Richmond, Va., where he is a professor of internal medicine and adjunct professor in pediatric medicine at the VCU School of Medicine. We talk about new genetic discoveries in biliary atresia and the future goals of research on this important pediatric liver topic.

For Canadian listeners:

Please note that all listed Bowel Sounds episodes are peer-reviewed and that listening to episodes is considered a Section Two Scanning Activity by the Royal College of Physicians and Surgeons of Canada Maintenance of Certification program. Each episode is valued at 0.5 Section Two Credits. Content is valid on the date recorded but recommendations may change over time. You can document your listening and obtain your CME credits at https://mainport.royalcollege....

CONTINUING EDUCATION (CE) LANGUAGE

Title:                   Emerging Therapeutic Frontiers in Pediatric IBD: IL-23 Blockade, JAK Inhibitors and Subcutaneous Biologics

Date:                   February 25, 2026

Location:             Online

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). NASPGHAN is accredited by the ACCME to provide continuing medical education for physicians.

ACCME provider number: 0005000

Credit Designation Statement

NASPGHAN designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

ABP MOC Part 2 Credits

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn up to 1.5 MOC Part 2 points for the live webinar in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Participant must complete the assessment within 30 days of the activity.

As therapeutic options for pediatric inflammatory bowel disease (IBD) rapidly evolve, clinicians must stay current on the next generation of therapies that have the potential to dramatically enhance patient outcomes and quality of life.

Emerging Therapeutic Frontiers in Pediatric IBD brings you an interactive, case-driven webinar that will delve into three groundbreaking areas transforming pediatric IBD care: IL-23 Blockade, JAK Inhibitors and Subcutaneous Biologic Medications. 

Expert faculty will guide attendees through mechanisms of action, clinical trial outcomes, real-world evidence, and safety considerations, offering up-to-date insights that bridge cutting-edge research and everyday practice. By the end of this webinar, participants will be equipped with practical strategies to integrate these novel therapies into comprehensive treatment plans, optimize disease monitoring, and collaborate effectively with multidisciplinary teams, ultimately advancing care for children living with IBD.

CONTINUING EDUCATION (CE) LANGUAGE

Title:                   Emerging Therapeutic Frontiers in Pediatric IBD: IL-23 Blockade, JAK Inhibitors and Subcutaneous Biologics

Date:                   February 25, 2026

Location:             Online

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). NASPGHAN is accredited by the ACCME to provide continuing medical education for physicians.

ACCME provider number: 0005000

Credit Designation Statement

NASPGHAN designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

ABP MOC Part 2 Credits

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn up to 1.5 MOC Part 2 points for the live webinar in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Participant must complete the assessment within 30 days of the activity.

As therapeutic options for pediatric inflammatory bowel disease (IBD) rapidly evolve, clinicians must stay current on the next generation of therapies that have the potential to dramatically enhance patient outcomes and quality of life.

Emerging Therapeutic Frontiers in Pediatric IBD brings you an interactive, case-driven webinar that will delve into three groundbreaking areas transforming pediatric IBD care: IL-23 Blockade, JAK Inhibitors and Subcutaneous Biologic Medications. 

Expert faculty will guide attendees through mechanisms of action, clinical trial outcomes, real-world evidence, and safety considerations, offering up-to-date insights that bridge cutting-edge research and everyday practice. By the end of this webinar, participants will be equipped with practical strategies to integrate these novel therapies into comprehensive treatment plans, optimize disease monitoring, and collaborate effectively with multidisciplinary teams, ultimately advancing care for children living with IBD.

In this episode, Drs. Jason Silverman and Jennifer Lee talk to Dr. Paul Wales all about the surgical management of short bowel syndrome, including decision-making based on initial presentation and important considerations for any autologous reconstruction procedure.

For Canadian listeners:

Please note that all listed Bowel Sounds episodes are peer-reviewed and that listening to episodes is considered a Section Two Scanning Activity by the Royal College of Physicians and Surgeons of Canada Maintenance of Certification program. Each episode is valued at 0.5 Section Two Credits. Content is valid on the date recorded but recommendations may change over time. You can document your listening and obtain your CME credits at https://mainport.royalcollege....

In this episode of Bowel Sounds, hosts Dr. Temara Hajjat and Dr. Peter Lu talk to Dr. Cynthia Akagbosu, a pediatric gastroenterologist and Assistant Professor at Columbia University Irving Medical Center, who is board-certified in pediatrics, pediatric gastroenterology, and obesity medicine. 

Dr. Akagbosu discusses indications, side effects, and types of endobariatrics in pediatric patients. 

For Canadian listeners:

Please note that all listed Bowel Sounds episodes are peer-reviewed and that listening to episodes is considered a Section Two Scanning Activity by the Royal College of Physicians and Surgeons of Canada Maintenance of Certification program. Each episode is valued at 0.5 Section Two Credits. Content is valid on the date recorded but recommendations may change over time. You can document your listening and obtain your CME credits at https://mainport.royalcollege.ca

Efficacy of low volume transanal irrigation in children with retentive fecal incontinence: A randomized controlled trial, February 2026 JPGN